Hyperbaric oxygen (HBO) therapy as an effective approach to the treatment of patients with severe idiopathic sudden sensorineural hearing loss

被引：18

作者：

Choi, Yeonjoo ^{[1
]}

Choi, Hye Lim ^{[2
]}

Jeong, A. Young ^{[2
]}

Kang, Woo Seok ^{[1
]}

Park, Hong Ju ^{[1
]}

Chung, Jong Woo ^{[1
]}

Ahn, Joong Ho ^{[1
]}

机构：

[1] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Otolaryngol Head & Neck Surg, 88,Olymp Ro 43 Gil, Seoul 05505, South Korea

[2] Univ Szeged, Fac Med, Szeged, Hungary

来源：

ACTA OTO-LARYNGOLOGICA | 2020年 / 140卷 / 05期

关键词：

Sudden sensorineural hearing loss; severe hearing loss; hyperbaric oxygen therapy; STEROIDS;

D O I：

10.1080/00016489.2020.1717607

中图分类号：

R76 [耳鼻咽喉科学];

学科分类号：

100213 ;

摘要：

Background: The potential etiology of idiopathic sudden sensorineural hearing loss (ISSNHL) is cochlear ischemia, therefore, hyperbaric oxygen (HBO) therapy is a promising treatment, particularly in patients with severe hearing loss (>= 70 dB). Aims/objectives: To evaluate the efficacy of HBO therapy. Material and methods: The medical records of patients diagnosed with ISSNHL were retrospectively reviewed (>= 70 dB). Patients received HBO therapy 14 times in addition to systemic and intratympanic steroid therapy (HBO group), or systemic and intratympanic steroid therapy only (control group). Results: Data from a total of 82 patients (83 ears) were included in the analysis; 37 (38 ears) in the HBO group and 45 (45 ears) in the control group. After 2 weeks' treatment, hearing was significantly improved in the HBO group versus controls (weighted four-frequency average 28.1 +/- 26.9 dB versus 14.8 +/- 13.5 dB, respectively; p < .05), particularly in the low frequency groups (0.5 kHz, 1 kHz, 2 kHz; p < .05).

引用

页码：383 / 386

页数：4

共 20 条

[1] Efficacy comparison of oral steroid, intratympanic steroid, hyperbaric oxygen and oral steroid plus hyperbaric oxygen treatments in idiopathic sudden sensorineural hearing loss cases [J].

Alimoglu, Yalcin ;

Inci, Ender ;

Edizer, Deniz Tuna ;

Ozdilek, Alper ;

Aslan, Mehmet .

EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2011, 268 (12) :1735-1741

[2] Titration streptomycin therapy in Meniere's disease: Long-term results [J].

Balyan, FR ;

Taibah, A ;

De Donato, G ;

Aslan, A ;

Falcioni, M ;

Russo, A ;

Sanna, M .

OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 1998, 118 (02) :261-266

[3] Hyperbaric oxygen for idiopathic sudden sensorineural hearing loss and tinnitus [J].

Bennett, Michael H. ;

Kertesz, Tom ;

Perleth, Matthias ;

Yeung, Philip ;

Lehm, Jan P. .

COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (10)

[4]

Camporesi EM, 2014, UNDERSEA HYPERBAR M, V41, P253

[5] Intratympanic dexamethasone for sudden sensorineural hearing loss: Clinical and laboratory evaluation [J].

Chandrasekhar, SS .

OTOLOGY & NEUROTOLOGY, 2001, 22 (01) :18-23

[6] Distribution of Na,K-ATPase is normal in the inner ear of a mouse with a null mutation of the glucocorticoid receptor [J].

Erichsen, S ;

Stierna, P ;

Bagger-Sjöbäck, D ;

Curtis, LM ;

Rarey, KE ;

Schmid, W ;

Hultcrantz, M .

HEARING RESEARCH, 1998, 124 (1-2) :146-154

[7] Hyperbaric oxygen and steroid therapy for idiopathic sudden sensorineural hearing loss [J].

Fujimura, Takeyuki ;

Suzuki, Hideaki ;

Shiomori, Teruo ;

Udaka, Tsuyoshi ;

Mori, Takanori .

EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2007, 264 (08) :861-866

[8]

Hadanny A, 2016, UNDERSEA HYPERBAR M, V43, P113

[9]

Hughes GB, 1996, OTOLARYNG CLIN N AM, V29, P393

[10]

LAMM C, 1988, HNO, V36, P363

← 1 2 →